Delpharm

🚀 𝐌𝐞𝐞𝐭 𝐃𝐞𝐥𝐩𝐡𝐚𝐫𝐦 𝐚𝐭 𝐃𝐂𝐀𝐓 𝐖𝐞𝐞𝐤 𝟐𝟎𝟐𝟓! 📅 𝐌𝐚𝐫𝐜𝐡 𝟏𝟕-𝟐𝟎 | 📍 𝐋𝐨𝐭𝐭𝐞 𝐍𝐞𝐰 𝐘𝐨𝐫𝐤 𝐏𝐚𝐥𝐚𝐜𝐞 Are you attending DCAT Week 2025 in New York? Let’s connect! Delpharm will be present, and we would love to meet with you to discuss how we can support your pharmaceutical projects. 𝐎𝐮𝐫 𝐞𝐱𝐩𝐞𝐫𝐭𝐢𝐬𝐞 𝐚𝐜𝐫𝐨𝐬𝐬 𝐦𝐮𝐥𝐭𝐢𝐩𝐥𝐞 𝐝𝐨𝐬𝐚𝐠𝐞 𝐟𝐨𝐫𝐦𝐬: ✅ Sterile Forms – Prefilled syringes (PFS), vials, ampoules, and freeze-drying (lyophilization) ✅ High Potent & Oncology – Manufacturing of solids, liquids, and semi-solids up to OEB5 ✅ Nasal Sprays & Semi-Solids – Advanced capabilities in creams, ointments, gels, and suppositories ✅ Oral Solids – Tablets (film/sugar-coated, bi-layer, effervescent), capsules, pellets, powders, and granules ✅ Liquids & Suspensions – Oral solutions, syrups, drops, and topical sprays ✅ Softgel Capsules – High potent and standard formulations ✅ Microspheres & Complex Injectables – Advanced long-acting formulations ✅ Sachets – Expertise in granules and powders for single-dose packaging ✅ Development Services – Full support from formulation to regulatory approval Delpharm is your CDMO partner of choice for a wide range of sterile, solid, liquid, and semi-solid drug forms, including high potent compounds, sachets, and complex formulations. 📅 𝐒𝐜𝐡𝐞𝐝𝐮𝐥𝐞 𝐚 𝐦𝐞𝐞𝐭𝐢𝐧𝐠 𝐢𝐧 𝐚𝐝𝐯𝐚𝐧𝐜𝐞 𝐚𝐭 𝐝𝐞𝐥𝐩𝐡𝐚𝐫𝐦.𝐝𝐜𝐚𝐭@𝐝𝐞𝐥𝐩𝐡𝐚𝐫𝐦.𝐜𝐨𝐦. We look forward to seeing you in New York! 🌎💊 #DCATWeek2025 #CDMO #healthcare

𝐋𝐨𝐨𝐤𝐢𝐧𝐠 𝐟𝐨𝐫 𝐚 𝐬𝐮𝐬𝐭𝐚𝐢𝐧𝐚𝐛𝐥𝐞 𝐂𝐃𝐌𝐎 𝐢𝐧 𝐍𝐨𝐫𝐭𝐡 𝐀𝐦𝐞𝐫𝐢𝐜𝐚? With 100% renewable electricity, Delpharm Montréal is your next sustainable partner. With a highly qualified teams, the site is ready to manufacture and package your next projects in nasal sprays, semi-solids and liquids. 👉 To know more, visit Delpharm website: https://lnkd.in/dzUqUaV

🚨 𝐑𝐞𝐩𝐥𝐚𝐜𝐢𝐧𝐠 𝐓𝐢𝐎𝟐 𝐢𝐧 𝐌𝐞𝐝𝐢𝐜𝐢𝐧𝐞𝐬: 𝐀 𝐒𝐭𝐫𝐚𝐭𝐞𝐠𝐢𝐜 𝐃𝐞𝐜𝐢𝐬𝐢𝐨𝐧 𝐟𝐨𝐫 𝐏𝐡𝐚𝐫𝐦𝐚𝐜𝐞𝐮𝐭𝐢𝐜𝐚𝐥 𝐋𝐚𝐛𝐨𝐫𝐚𝐭𝐨𝐫𝐢𝐞𝐬 🚨 Since the ban on TiO2 in food supplements in August 2022, the question of replacing this crucial excipient in medicines has become increasingly urgent. Should the composition be reformulated or adapted? The answer depends on several key factors: 🔹 Pharmaceutical form: coated tablets, capsules, etc. 🔹 Role of TiO2: whitening, opacification, or UV light protection. 🔹 Retaining the original colour: is it essential for the final product? The solutions offered include either the complete removal of TiO2 or its replacement with another excipient. The best solution depends on each project and involves anticipating and adapting the formulas to meet regulatory challenges and ensure the quality of medicines. 🔬 Contact us to discuss: development@delpharm.com #regulatory #biotech #startup #delpharm

𝐌𝐞𝐞𝐭 𝐃𝐞𝐥𝐩𝐡𝐚𝐫𝐦 𝐚𝐭 𝐁𝐢𝐨 𝐄𝐮𝐫𝐨𝐩𝐞 𝐒𝐩𝐫𝐢𝐧𝐠 𝟐𝟎𝟐𝟓 𝐟𝐫𝐨𝐦 𝐌𝐚𝐫𝐜𝐡 𝟏𝟕-𝟏𝟗 𝐚𝐭 𝐌𝐢𝐥𝐚𝐧, 𝐈𝐭𝐚𝐥𝐲. Our development BD team will be pleased to discuss your development projects and meet at our booth 56. 📧 To schedule a meeting with us, please send us a message via PartneringOne or via email at development@delpharm.com. #Delpharm #BioEuropeSpring

𝐎𝐧 𝐅𝐞𝐛𝐫𝐮𝐚𝐫𝐲 𝟐𝟖, 𝐖𝐨𝐫𝐥𝐝 𝐑𝐚𝐫𝐞 𝐃𝐢𝐬𝐞𝐚𝐬𝐞 𝐃𝐚𝐲, 𝐃𝐞𝐥𝐩𝐡𝐚𝐫𝐦 𝐰𝐨𝐮𝐥𝐝 𝐥𝐢𝐤𝐞 𝐭𝐨 𝐫𝐞𝐚𝐟𝐟𝐢𝐫𝐦 𝐢𝐭𝐬 𝐬𝐮𝐩𝐩𝐨𝐫𝐭 𝐟𝐨𝐫 𝐚𝐥𝐥 𝐭𝐡𝐨𝐬𝐞 𝐚𝐟𝐟𝐞𝐜𝐭𝐞𝐝 𝐛𝐲 𝐚 𝐫𝐚𝐫𝐞 𝐝𝐢𝐬𝐞𝐚𝐬𝐞. Today, 300 million people live with a disease considered rare. This figure proves that the search for suitable treatments is essential if these people are to be correctly diagnosed and treated. Delpharm understands this, and would like to thank DELPHARM LILLE, DELPHARM EVREUX and DELPHARM REIMS for their contribution to the production of treatments for certain rare diseases. Indeed, the Lille and Evreux sites are involved in the production of capsules for Wilson's disease, a pathology which leads to an abnormal accumulation of copper in organs, very often the liver and brain. The Reims site is also involved in the production of tablets for Gaucher disease type 1, which causes anemia and bone pathologies, and for Niemann-Pick disease, which leads to growth deficiency and neurological degradation. Improving the health and quality of life of the patients concerned is our priority. #Delpharm #healthcare #cdmo

📢 𝐌𝐞𝐞𝐭 𝐃𝐞𝐥𝐩𝐡𝐚𝐫𝐦 𝐚𝐭 𝐃𝐂𝐀𝐓 𝐖𝐞𝐞𝐤 𝟐𝟎𝟐𝟓 #Delpharm will be in #DCAT Week 2025 from March 17th to 20th, in New York Lotte Palace. We will be pleased to discuss your development and manufacturing projects. 📧 To schedule your meeting, please email us at delpharm.dcat@delpharm.com. Hoping to meet you soon!

𝐎𝐧 𝐭𝐡𝐢𝐬 𝐝𝐚𝐲, 𝐈𝐧𝐭𝐞𝐫𝐧𝐚𝐭𝐢𝐨𝐧𝐚𝐥 𝐃𝐚𝐲 𝐨𝐟 𝐒𝐨𝐜𝐢𝐚𝐥 𝐉𝐮𝐬𝐭𝐢𝐜𝐞, 𝐰𝐞 𝐰𝐚𝐧𝐭𝐞𝐝 𝐭𝐨 𝐫𝐞𝐦𝐢𝐧𝐝 𝐲𝐨𝐮 𝐭𝐡𝐚𝐭 𝐚𝐭 𝐃𝐞𝐥𝐩𝐡𝐚𝐫𝐦, 𝐰𝐞 𝐛𝐞𝐥𝐢𝐞𝐯𝐞 𝐭𝐡𝐚𝐭 𝐬𝐨𝐜𝐢𝐚𝐥 𝐣𝐮𝐬𝐭𝐢𝐜𝐞 𝐢𝐬 𝐚 𝐩𝐢𝐥𝐥𝐚𝐫 𝐨𝐟 𝐬𝐮𝐬𝐭𝐚𝐢𝐧𝐚𝐛𝐥𝐞 𝐩𝐫𝐨𝐠𝐫𝐞𝐬𝐬. As a committed company, we work every day to build a working environment that is inclusive, fair and respectful of human rights. Some of our actions in favor of social justice: 🔷 𝗚𝗲𝗻𝗱𝗲𝗿 𝗲𝗾𝘂𝗮𝗹𝗶𝘁𝘆: 43% of our employees are women, with a steadily rising rate of female managers since 2021 🔷 𝗗𝗶𝘃𝗲𝗿𝘀𝗶𝘁𝘆 𝗮𝗻𝗱 𝗶𝗻𝗰𝗹𝘂𝘀𝗶𝗼𝗻: We are committed to guaranteeing equal opportunities, from recruitment onwards and throughout careers, and to respecting the rights of everyone. 🔷 𝗦𝘂𝗽𝗽𝗼𝗿𝘁 𝗳𝗼𝗿 𝗹𝗼𝗰𝗮𝗹 𝗰𝗼𝗺𝗺𝘂𝗻𝗶𝘁𝗶𝗲𝘀: We collaborate with associations and solidarity initiatives such as clothing drives and support for the employment of people with disabilities. 🔷 𝗥𝗲𝘀𝗽𝗲𝗰𝘁 𝗳𝗼𝗿 𝘄𝗼𝗿𝗸𝗲𝗿𝘀' 𝗿𝗶𝗴𝗵𝘁𝘀: Health, safety and optimum working conditions for our employees at all our sites. Social justice is more than just an ideal: it is a daily commitment. On this special day, we reaffirm our dedication to building a fairer world for all. #Delpharm #culture #humanresources

𝐎𝐧 𝐅𝐞𝐛𝐫𝐮𝐚𝐫𝐲 𝟏𝟐, 𝐈𝐧𝐭𝐞𝐫𝐧𝐚𝐭𝐢𝐨𝐧𝐚𝐥 𝐄𝐩𝐢𝐥𝐞𝐩𝐬𝐲 𝐃𝐚𝐲, 𝐃𝐞𝐥𝐩𝐡𝐚𝐫𝐦 𝐫𝐞𝐚𝐟𝐟𝐢𝐫𝐦𝐬 𝐢𝐭𝐬 𝐬𝐮𝐩𝐩𝐨𝐫𝐭 𝐟𝐨𝐫 𝐚𝐥𝐥 𝐩𝐞𝐨𝐩𝐥𝐞 𝐰𝐢𝐭𝐡 𝐞𝐩𝐢𝐥𝐞𝐩𝐬𝐲. Affecting 50 million people worldwide, epilepsy is one of the most widespread neurological disorders. Some studies put the proportion of people with epilepsy who could live seizure-free if correctly diagnosed and treated at 70%, a statistic which proves that every effort must be made to diagnose and treat patients correctly. #Delpharm understands this need and would like to thank DELPHARM BRÉTIGNY, DELPHARM ORLEANS and DELPHARM LILLE for their ongoing efforts in the production of anti-epileptic treatment. Improving the health and quality of life of those affected is our priority.  #healthcare #cdmo

👨🔬🔬 𝐓𝐨 𝐜𝐞𝐥𝐞𝐛𝐫𝐚𝐭𝐞 𝐭𝐡𝐞 𝐈𝐧𝐭𝐞𝐫𝐧𝐚𝐭𝐢𝐨𝐧𝐚𝐥 𝐃𝐚𝐲 𝐨𝐟 𝐖𝐨𝐦𝐞𝐧 𝐚𝐧𝐝 𝐆𝐢𝐫𝐥𝐬 𝐢𝐧 𝐒𝐜𝐢𝐞𝐧𝐜𝐞, 𝐦𝐞𝐞𝐭 𝐚 𝐃𝐞𝐥𝐩𝐡𝐚𝐫𝐦 𝐥𝐚𝐛𝐨𝐫𝐚𝐭𝐨𝐫𝐲 𝐭𝐞𝐜𝐡𝐧𝐢𝐜𝐢𝐚𝐧, 𝐰𝐡𝐨 𝐬𝐡𝐚𝐫𝐞𝐝 𝐰𝐢𝐭𝐡 𝐲𝐨𝐮 𝐡𝐞𝐫 𝐢𝐧𝐬𝐩𝐢𝐫𝐢𝐧𝐠 𝐜𝐚𝐫𝐞𝐞𝐫 𝐩𝐚𝐭𝐡 𝐚𝐧𝐝 𝐡𝐞𝐫 𝐩𝐚𝐬𝐬𝐢𝐨𝐧 𝐟𝐨𝐫 𝐡𝐞𝐫 𝐩𝐫𝐨𝐟𝐞𝐬𝐬𝐢𝐨𝐧. With a DUT in chemical and process engineering, she obtained her first permanent contract at #Delpharm. Her passion for the scientific world was revealed during a laboratory internship in high school, a turning point that steered her towards this career. Over the last 5 years at Delpharm, she has been able to explore a wide range of assignments: 🔹 analysis of raw materials and finished products, equipment qualification 🔹 SAP inventory management 🔹 improvement projects such as the complete reorganization of reagent management within the laboratory. She particularly appreciates the diversity of tasks and the variety of analyses performed on a daily basis, which enables the use of a wide range of equipment. She also highlights the good representation of women at the DELPHARM BRÉTIGNY. Her advice: "𝘎𝘰 𝘧𝘰𝘳 𝘪𝘵, 𝘵𝘳𝘺 𝘪𝘵 𝘰𝘶𝘵 𝘢𝘯𝘥 𝘧𝘪𝘯𝘥 𝘸𝘩𝘢𝘵 𝘴𝘶𝘪𝘵𝘴 𝘺𝘰𝘶." For her, Delpharm is an ideal school for young graduates, offering training, versatility and a caring environment. #personalbranding #storytelling

𝐎𝐧 𝐅𝐞𝐛𝐫𝐮𝐚𝐫𝐲 𝟒, 𝐖𝐨𝐫𝐥𝐝 𝐂𝐚𝐧𝐜𝐞𝐫 𝐃𝐚𝐲, 𝐃𝐞𝐥𝐩𝐡𝐚𝐫𝐦 𝐰𝐨𝐮𝐥𝐝 𝐥𝐢𝐤𝐞 𝐭𝐨 𝐫𝐞𝐚𝐟𝐟𝐢𝐫𝐦 𝐢𝐭𝐬 𝐬𝐮𝐩𝐩𝐨𝐫𝐭 𝐟𝐨𝐫 𝐩𝐚𝐭𝐢𝐞𝐧𝐭𝐬 𝐚𝐟𝐟𝐞𝐜𝐭𝐞𝐝 𝐛𝐲 𝐜𝐚𝐧𝐜𝐞𝐫. Today, one in every six deaths is attributed to a form of cancer, making it one of the world's leading causes of death. Cancer must be fought with strength, and #Delpharm and its associates have understood this and are striving to bring solutions to the patients affected. Delpharm would like to thank DELPHARM LILLE for its contribution to the production of treatments for prostate, breast and leukemia cancers. As well as DELPHARM NOVARA site for its contribution to cancer treatments and DELPHARM MEPPEL for the production of treatment for acute myeloid leukemia. Improving the health and quality of life of cancer patients is our priority. #CDMO #healthcare